{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:49:29Z","timestamp":1777312169816,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002538"],"award-info":[{"award-number":["UL1TR002538"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00246-022-02976-z","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T19:20:25Z","timestamp":1659036025000},"page":"618-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome: Impact on Prescription Practices"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-8854","authenticated-orcid":false,"given":"Dwight M.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongngan T.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harris L.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhining","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. LuAnn","family":"Minich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard V.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Seda","family":"Selamet Tierney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2976_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annnurev.med.51.1.481","volume":"51","author":"RE Pyeritz","year":"2000","unstructured":"Pyeritz RE (2000) The Marfan syndrome. Ann Rev Med 51:481\u2013510. https:\/\/doi.org\/10.1146\/annnurev.med.51.1.481","journal-title":"Ann Rev Med"},{"key":"2976_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz HC, Cutting GR, Pyertiz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, Meyers DA, Francomano CA (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin-1 gene. Nature 352:337\u2013339. https:\/\/doi.org\/10.1038\/352337a0","journal-title":"Nature"},{"issue":"19","key":"2976_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","volume":"330","author":"J Shores","year":"1994","unstructured":"Shores J, Berger KR, Murphy EA, Pyeritz RE (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan\u2019s syndrome. N Engl J Med 330(19):1335\u20131341. https:\/\/doi.org\/10.1056\/NEJM199405123301902","journal-title":"N Engl J Med"},{"issue":"4","key":"2976_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1017\/S1047951112001412","volume":"23","author":"V Thakur","year":"2013","unstructured":"Thakur V, Rankin KN, Hartling L, Mackie AS (2013) A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome. Cardiol Young 23(4):568\u2013581. https:\/\/doi.org\/10.1017\/S1047951112001412","journal-title":"Cardiol Young"},{"key":"2976_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(15)62106-4","author":"P Krishnamoorthy","year":"2015","unstructured":"Krishnamoorthy P, Garg J, Shah N, Sharma A, Jacobs L, Martinez M (2015) Effect of beta-blockers on progressive aortic dilatation in patients with Marfan\u2019s syndrome. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/S0735-1097(15)62106-4","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2976_CR6","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/01.CIR0000155243.70456.F4","volume":"111","author":"DM Milewicz","year":"2005","unstructured":"Milewicz DM, Dietz HC, Miller DC (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation 111(11):e150-157. https:\/\/doi.org\/10.1161\/01.CIR0000155243.70456.F4","journal-title":"Circulation"},{"issue":"5770","key":"2976_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770):117\u2013121. https:\/\/doi.org\/10.1126\/science.1124287","journal-title":"Science"},{"issue":"2","key":"2976_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1172\/JCI42014","volume":"120","author":"HC Dietz","year":"2010","unstructured":"Dietz HC (2010) TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J Clin Investig 120(2):403\u2013407. https:\/\/doi.org\/10.1172\/JCI42014","journal-title":"J Clin Investig"},{"issue":"26","key":"2976_CR9","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMc081528","volume":"358","author":"BS Brooke","year":"2008","unstructured":"Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC (2008) Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome. N Engl J Med 358(26):2787\u20132795. https:\/\/doi.org\/10.1056\/NEJMc081528","journal-title":"N Engl J Med"},{"issue":"22","key":"2976_CR10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro RV, Dietz HC, Sleeper LA, Yteman AT, Bradley TJ, Colan SD, Pearson GD, Tierney ESS, Levine JC, Atz AM, Benson DW, Braverman AC, Chen S, De Backer J, Gelb BD, Grossfeld PD, Klein GL, Lai WW, Liou A, Loeys BL, Markham LW, Olson AK, Paridon SM, Pemberton VL, Pierpont ME, Pyeritz RE, Radojewski E, Roman MJ, Sharkey AM, Stylianou MP, Burns Wechsler S, Young LT, Mahony L (2014) Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome. N Engl J Med 371(22):2061\u20132071. https:\/\/doi.org\/10.1056\/NEJMoa1404731","journal-title":"N Engl J Med"},{"issue":"1","key":"2976_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.publhealth.031308.100049","volume":"30","author":"LW Green","year":"2009","unstructured":"Green LW, Ottoson JM, Garcia C, Hiatt RA (2009) Diffusion theory and knowledge dissemination, utilization, and integration in public health. Annu Rev Public Health 30(1):151\u2013174. https:\/\/doi.org\/10.1146\/annurev.publhealth.031308.100049","journal-title":"Annu Rev Public Health"},{"key":"2976_CR12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1637943","author":"EA Balas","year":"2000","unstructured":"Balas EA, Boren SA (2000) Managing clinical knowledge for health care improvement. Yearb Med Inform. https:\/\/doi.org\/10.1055\/s-0038-1637943","journal-title":"Yearb Med Inform"},{"issue":"4","key":"2976_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","volume":"154","author":"RV Lacro","year":"2007","unstructured":"Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB, Klein GL, Li JS, Minich LL, Paridon SM, Pearson GD, Printz BF, Pyeritz RE, Radojewski E, Roman MJ, Saul JP, Stylianou MP, Mahony L (2007) Rationale and design of a randomized clinical trial of beta blocker therapy (atenolol) vs. angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 154(4):624\u2013631. https:\/\/doi.org\/10.1016\/j.ahj.2007.06.024","journal-title":"Am Heart J"},{"issue":"9","key":"2976_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.amjcard.2005.01.032","volume":"95","author":"AT Yetman","year":"2005","unstructured":"Yetman AT, Bornemeier RA (2005) Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 95(9):1125\u20131127. https:\/\/doi.org\/10.1016\/j.amjcard.2005.01.032","journal-title":"Am J Cardiol"},{"issue":"2","key":"2976_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1536867X1501500208","volume":"15","author":"A Linden","year":"2015","unstructured":"Linden A (2015) Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stand Genomic Sci 15(2):480\u2013500. https:\/\/doi.org\/10.1177\/1536867X1501500208","journal-title":"Stand Genomic Sci"},{"issue":"4","key":"2976_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27(4):299\u2013309. https:\/\/doi.org\/10.1046\/j.1365-2710.2002.00430.x","journal-title":"J Clin Pharm Ther"},{"key":"2976_CR17","unstructured":"R Core Team (2020) R: a language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.R-project.org\/"},{"key":"2976_CR18","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","volume":"117","author":"MG Keane","year":"2008","unstructured":"Keane MG, Pyeritz RE (2008) Medical management of Marfan syndrome. Circulation 117:2802\u20132813. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.693523","journal-title":"Circulation"},{"issue":"4","key":"2976_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/hrt.2006.109454","volume":"94","author":"A Williams","year":"2008","unstructured":"Williams A, Davies S, Stuart AG, Wilson DG, Fraser AG (2008) Medical treatment of Marfan syndrome: a time for change. Heart 94(4):414\u2013421. https:\/\/doi.org\/10.1136\/hrt.2006.109454","journal-title":"Heart"},{"issue":"5","key":"2976_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00246-021-02606-0","volume":"42","author":"DL Weyhrauch","year":"2021","unstructured":"Weyhrauch DL, Truong DT, Pinto NM, Amula V, Lambert LM, Zhang C, Presson AP, Wilkes J, Minich LL, Williams RV (2021) Changes in provider prescribing behavior for infants with single ventricle physiology after evidence-based publications. Pediatr Cardiol 42(5):1224\u20131232. https:\/\/doi.org\/10.1007\/s00246-021-02606-0","journal-title":"Pediatr Cardiol"},{"issue":"S2","key":"2976_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1017\/S1047951115000980","volume":"25","author":"K Hill","year":"2015","unstructured":"Hill K, Henderson H, Hornik CP, Li JS (2015) Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database. Cardiol Young 25(S2):172\u2013180. https:\/\/doi.org\/10.1017\/S1047951115000980","journal-title":"Cardiol Young"},{"issue":"3","key":"2976_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7326\/0003-4819-151-3-200908040-00126","volume":"151","author":"BR Luce","year":"2009","unstructured":"Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS (2009) Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 151(3):206\u2013209. https:\/\/doi.org\/10.7326\/0003-4819-151-3-200908040-00126","journal-title":"Ann Intern Med"},{"issue":"9","key":"2976_CR23","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.cjca.2021.06.013","volume":"37","author":"KC Harris","year":"2021","unstructured":"Harris KC, Mackie AS, Dallaire F, Khoury M, Singer J, Mahle WT, Klassen TP, McCrindle BW (2021) Unique challenges of randomized controlled trials in pediatric cardiology. Can J Cardiol 37(9):1394\u20131403. https:\/\/doi.org\/10.1016\/j.cjca.2021.06.013","journal-title":"Can J Cardiol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-022-02976-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-022-02976-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-022-02976-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:05:44Z","timestamp":1677143144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-022-02976-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2976"],"URL":"https:\/\/doi.org\/10.1007\/s00246-022-02976-z","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There were no competing financial interests in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}